Bridgecom Exhibits at California Association of Health Plans Conference in Palm Desert

MIRA LOMA, Calif., Oct. 17, 2019 /PRNewswire/ — Bridgecom, provider of a HIPAA-compliant, web-based patient outreach management platform, is excited to be attending the California Association of Health Plans Conference in Palm Desert, CA from October 21st – 23rd. For more than 40 years, the company has assisted in bridging the communication and care gaps that exist between health care and consumers, by offering patient-specific communications and personalized follow-up touch points. In addition to population health engagement solutions, the company also offers a standardized colorectal cancer (CRC) screening outreach program, which empowers members, accelerating patient compliance.

California Association of Health Plans (CAHP) is made up of 47 full-service health care plans that provide coverage to more than 26 million Californians. The annual event, now in its 34th year, “promotes opportunities and forums for plan members to meet, exchange ideas, and discuss critical issues facing the industry and industry effectiveness.” The association’s overall mission is to serve members by offering an environment that supports California health plans as they strive to provide affordable, high quality, accessible health care to their members.

Bridgecom is excited to join with over 1,000 like-minded health care professionals at the conference, with the common goal of improving the California health care landscape. “Our team is committed to delivering innovative solutions to the most challenging issues facing health care today,” said Bridgecom CEO Joel Luce. According to CAHP, this year, California has been dealing with many new laws and regulations, aimed at “expanding coverage, stabilizing the individual marketplace, and increase affordability to create a new opportunities to improve the health care system.” Attendees can look forward to learning how health plans in California are dealing with these changes, while also planning for the future.

About Bridgecom
Bridgecom is a software and services company that provides powerful solutions to close care gaps, improve patient outcomes and reduce avoidable risk, costs and complexity. Anchored by 30 years’ expertise in Medicare/Medicaid member communication fulfillment, Bridgecom’s web-based platform and workflow processes helps health payers, providers, accountable care organizations (ACOs) and medical groups standardize and distribute at-home fecal immunochemical test (FIT) colorectal cancer screening to target populations. The technology effectively engages recipients through personalized notifications designed to educate and drive them to action, achieving compliance. For information, visit https://www.bridgecomsolutions.com/.  

Media Contact:
Lesley Bellows
951-361-7326
marketing@bridgecomsolutions.com

http://www.cvent.com/events/cahp-s-34th-annual-conference/event-summary-e2b2b3cf977e4ee9ba5d9ad67b6c0011.aspx

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/bridgecom-exhibits-at-california-association-of-health-plans-conference-in-palm-desert-300939960.html

SOURCE Bridgecom

Staff

Recent Posts

AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd.

Strategic Expansion into Cardio AI-Driven Healthcare SolutionsCollaboration to Enhance Patient-Centered Digital Healthcare TechnologiesWelcomes Key Industry…

1 hour ago

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

15 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

16 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

16 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

17 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

19 hours ago